I see them as competing with PGL in this space of primary liver cancer, so if they can't make it to the next level I guess it is good news for PGL.
bioalliance pharma suspends phase ii iii trial, page-3
Add PGL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.5¢ |
Change
0.005(1.19%) |
Mkt cap ! $69.95M | |||
| Open | High | Low | Value | Volume |
| 42.0¢ | 42.5¢ | 42.0¢ | $25.12K | 59.36K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 42.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.0¢ | 4400 | 1 |
View Market Depth
| Last trade - 14.50pm 13/06/2024 (20 minute delay) ? |
| PGL (ASX) Chart |